June 21 news, Smith Bond technology disclosed investor relations activity records show that the company's investment project has been progressing smoothly since the start of construction, is expected to start trial production in the third quarter.
Question 1: When can the tetrahydrofuran project in the company's fundraising project be put into production? What positive impact will it have on the development of the company?
A: The project has been progressing smoothly since the start of construction, and trial production is expected to start in the third quarter. The project is planned to build a 30,000 tons/year tetrahydrofuran project. After the project is put into operation, it will further enhance the company's production and supply capacity of polymer-grade tetrahydrofuran, enrich the company's performance growth sources, enhance the company's comprehensive competitive strength, and consolidate and enhance the company's market position.
Question 2: Up to now, the supply situation of the company and Hyosung Spandex?
Answer: At present, the company has been continuing to supply Xiaoxing Spandex, and maintain a good cooperative relationship.
Question 3: What are the advantages of the company's mercury-free liquid catalyst and the current market situation?
Answer: The mercury-free ionic liquid catalyst developed by the company is an effective alternative to the current low mercury catalyst in the PVC industry by calcium carbide process. The technology of "mercury-free ionic liquid catalyst and gas-liquid catalytic reaction process and device for acetylene hydrochlorination synthesis VCM" supporting the catalyst has been certified as "International Leading Level" by the Department of Science and Technology of Hebei Province. It can meet the urgent needs of mercury-free catalyst and large-scale single conversion unit in PVC industry, and the technology has completed industrial side line verification, and is currently in the stage of industrialization and promotion.
Q4: What is the company's development strategy and positioning for synthetic biology?
Answer: Based on the research and development of advanced green manufacturing technology, the company will continue to provide green key technology solutions for the field of biological health, combining biosynthesis technology with the company's advantages. At present, the company has built biological enterprise technology center and biological pilot test platform, and has developed a number of green biological manufacturing technologies in the pilot and pilot stages, and is in the stage of industrial technology reserve.
